MBO2: A Protein Implicated in Cancer and Neurodegenerative Diseases

Target Name: CCDC146

NCBI ID: G57639

CCDC146

MBO2: A Protein Implicated in Cancer and Neurodegenerative Diseases

CCDC146 (MBO2) is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell division and has been implicated in the development and progression of many diseases. MBO2 has also been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The mechanism of action of MBO2 is not well understood, but it is known to play a role in the regulation of cell division and the control of cell growth. MBO2 is a transcription factor that is involved in the regulation of gene expression and has been shown to promote the expression of genes that are involved in cell growth and division.

One of the functions of MBO2 is to promote the production of polyploid cells, which are cells that have an extra copy of each chromosome. This process is called \"hyperplasia\" and is often seen in cancer cells. By promoting the production of polyploid cells, MBO2 may contribute to the development and progression of cancer.

Another function of MBO2 is its role in the regulation of cell apoptosis, or cell death. MBO2 has been shown to promote the production of programmed cell death (apoptosis) in response to various stimuli, including exposure to chemotherapy drugs. This may contribute to the anti-cancer effects of these drugs by promoting the death of cancer cells.

In addition to its role in cell growth and apoptosis, MBO2 is also involved in the regulation of cell adhesion. MBO2 has been shown to play a role in the formation of tight junctions, which are specialized structures that mediate the transfer of electrical signals from one cell to another. This may contribute to the regulation of cell-cell interactions and the maintenance of tissue structure.

MBO2 has also been implicated in the development and progression of neurodegenerative diseases. By promoting the production of polyploid cells and contributing to the regulation of cell apoptosis, MBO2 may contribute to the development of neurodegenerative diseases.

In addition to its potential role in neurodegenerative diseases, MBO2 has also been identified as a potential drug target for cancer. By inhibiting the activity of MBO2, researchers may be able to develop new treatments for cancer. This is an important area of research because cancer is a leading cause of death in the world.

The identification of MBO2 as a potential drug target and biomarker for cancer is an exciting area of research that has the potential to lead to new treatments for this disease. Further studies are needed to fully understand the role of MBO2 in cancer development and to develop effective treatments.

In conclusion, CCDC146 (MBO2) is a protein that is involved in the regulation of cell division and growth. It has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and developmental disorders. Further research is needed to fully understand the role of MBO2 in these diseases and to develop effective treatments.

Protein Name: Coiled-coil Domain Containing 146

The "CCDC146 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC146 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets